Skip to main content
. 2014 Mar 13;16(2):PCC.13f01514. doi: 10.4088/PCC.13f01514

Table 4.

Side Effect Risk Profiles of Common Second-Generation Antipsychotic Medications Used in Children and Adolescentsa

Second-Generation Antipsychotics
(trade name)
Anticholinergic Diabetes Hyperlipidemia Hyperprolactinemia Hypotension Sedation Tardive Dyskinesia Weight
Gain
Aripiprazole (Abilify) 0 + + 0 + + + +
Asenapine (Saphris) 0 + + + 0 + + +
Clozapine (Clozaril) +++ +++ ++/+++ 0 +++ +++ 0 +++
Iloperidone (Fanapt) 0 + + + + + + +
Lurasidone (Latuda) 0 + + + 0 + + +
Olanzapine (Zyprexa) ++ +++ ++/+++ +/++ + +/++ + +++
Paliperidone (Invega) 0 + +/++ ++ + + + ++
Quetiapine (Seroquel) 0/+ ++ +/++ 0 ++ ++ 0 ++
Risperidone (Risperdal) 0 + +/++ ++ ++ + + ++
Ziprasidone (Geodon) 0 + + 0 + + + +
a

Based on Celano et al80 and Correll et al.81

Symbols: 0 = low risk, + = mild risk, ++ = moderate risk, +++ = high risk.